Chemotherapy combined with anlotinib, toripalimab and stereotactic radiotherapy in oligo-metastatic nasopharyngeal carcinoma: A prospective, multicenter phase II clinical study

被引：0
|
作者：
Yang, Dong
Hu, Xueying
Ruan, Lin
Yang, Zhendong
Zhang, Tingting
Qin, Yutao
Liu, Kang
Liang, Fangfang
Qin, Yating
Huang, Heqing
Li, Pian
Du, Guobo
Lu, Ying
Han, Yaqian
Wang, Rensheng
Kang, Min
机构：
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Nanning, Guangxi, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Oncol, Nanning, Peoples R China
[3] Affiliated Hosp North Sichuan Med Coll, Dept Oncol, Nanchong, Peoples R China
[4] Liuzhou Workers Hosp, Liuzhou, Peoples R China
[5] Cent South Univ, Affiliated Canc Hosp Xiangya Sch Med, Hunan Canc Hosp, Changsha, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18011
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anlotinib Combined With Toripalimab as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Prospective, Multicenter, Phase II Study
    Zhang, Cheng-Sheng
    Zeng, Zhi-Ming
    Zhuo, Man-Yun
    Luo, Jing-Ru
    Zhuang, Xiao-Hong
    Xu, Jun-Nv
    Zeng, Jie
    Ma, Jie
    Lin, Hai-Feng
    [J]. ONCOLOGIST, 2023, : e1239 - e1247
  • [2] Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study
    Mo, Yunyan
    Pan, Yufei
    Zhang, Bin
    Zhang, Jian
    Su, Yixin
    Liu, Zhengchun
    Luo, Meiqing
    Qin, Guanjie
    Kong, Xiangyun
    Zhang, Rongjun
    Pan, Yu
    Liang, Yi
    Wang, Defeng
    Wei, Yuejia
    Chen, Hengwei
    Jiang, Wei
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [3] The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients
    H. Shuang
    J. Feng
    C. Caineng
    J. Qifeng
    J. Tin
    C. Yuanyuan
    C. Xiaozhong
    [J]. Clinical and Translational Oncology, 2019, 21 : 213 - 219
  • [4] Anlotinib for patients with recurrent or metastatic nasopharyngeal carcinoma: A phase II study.
    Cai, Qingqing
    Su, Ning
    Fang, Yu
    Zou, Qihua
    Xia, Yi
    Ma, Shuyun
    Cai, Jun
    Liu, PanPan
    Wang, Jinni
    Zhang, Yuchen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18020 - E18020
  • [5] The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients
    Shuang, H.
    Feng, J.
    Caineng, C.
    Qifeng, J.
    Tin, J.
    Yuanyuan, C.
    Xiaozhong, C.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (02): : 213 - 219
  • [6] Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study.
    Jiang, Feng
    Chen, Xiaozhong
    Liu, Tongxin
    Qin, WeiFeng
    Huang, Shuang
    Cao, Caineng
    Jin, Ting
    Jin, Qifeng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18071 - E18071
  • [7] Toripalimab in combination with anlotinib in previously treated recurrent or metastatic nasopharyngeal carcinoma: The interim analysis of the single-arm, phase II TORAL study
    Cai, Q.
    Zou, Q.
    Zhang, Y.
    Xia, Y.
    Liu, P.
    Su, N.
    Wang, J.
    Tian, X.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S579 - S579
  • [8] Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial
    Chen, Si-Yuan
    Duan, Xiao-Tong
    Li, Hui-Feng
    Peng, Lan
    Wang, Zhi-Qiang
    Xu, Gui-Qiong
    Hua, Yi-Jun
    Zou, Xiong
    You, Rui
    Ouyang, Yan-Feng
    Liu, You-Ping
    Gu, Chen-Mei
    Yang, Qi
    Jiang, Rou
    Zhang, Meng-Xia
    Lin, Mei
    Xie, Yu-Long
    Lin, Chao
    Ding, Xi
    Xie, Ruo-Qi
    Duan, Chong-Yang
    Zhang, Wei-Jing
    Huang, Pei-Yu
    Chen, Ming-Yuan
    [J]. CELL REPORTS MEDICINE, 2023, 4 (11)
  • [9] Induction chronomodulated chemotherapy plus radiotherapy for nasopharyngeal carcinoma: A Phase II prospective randomized study
    Gou, Xiao-Xia
    Jin, Feng
    Wu, Wei-Li
    Long, Jin-Hua
    Li, Yuan-Yuan
    Gong, Xiu-Yun
    Chen, Guo-Yan
    Chen, Xiao-Xiao
    Liu, Li-Na
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (07) : 1613 - 1619
  • [10] Gemcitabine and cisplatin chemotherapy plus penpulimab combined with or without anlotinib as neoadjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: A prospective, phase II clinical trial
    Mai, Hai-Qiang
    Sun, Xue-Song
    Liu, Li-Ting
    Guo, Shan-Shan
    Liu, Sai Lan
    Li, Xiao-Yun
    Li, Yi-Fu
    Wen, Dongxiang
    Long, Hao-Xiang
    Chen, Qiu-Yan
    Tang, Lin-Quan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345